These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 34184311)

  • 1. Gender disparities in isotretinoin prescribing patterns for pediatric patients before and during practice changes introduced by the COVID-19 pandemic.
    Tan AJ; Xia J; Herringshaw E; Mayur O; Iqbal A; Cucka B; Biglione B; Locascio JJ; Kroshinsky D
    Pediatr Dermatol; 2023; 40(5):869-872. PubMed ID: 37495565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Removal of Isotretinoin Gender-Based Guidelines: Inclusivity Takes Precedence.
    Nanda S
    Cutis; 2022 Mar; 109(3):E18-E20. PubMed ID: 35659135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Readability of iPledge materials for isotretinoin education in English and Spanish.
    DeMeo D; Reddy HA; Cowden MP; Maytin AK; Carroll BT
    Arch Dermatol Res; 2023 Sep; 315(7):2175-2178. PubMed ID: 36918437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Falsification of at-home isotretinoin pregnancy testing during the COVID-19 pandemic: A case series and proposal of mitigation strategies.
    Johnson H; Ranum A; Mansh M; Farah RS; Pearson DR
    JAAD Case Rep; 2022 Oct; 28():49-53. PubMed ID: 35971550
    [No Abstract]   [Full Text] [Related]  

  • 5. The Importance of Gender-Neutral Terminology in Risk Evaluation and Mitigation Strategy Programs: A Call to Action.
    Burnette C; Smithy W; Strock D; Sivesind TE; Dellavalle R
    JMIR Dermatol; 2023 Jun; 6():e45329. PubMed ID: 37632908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Home pregnancy tests for iPLEDGE: ethically dealing with potential falsifications.
    Schwartzman G; Flowers H; Grant-Kels JM
    Int J Womens Dermatol; 2023 Oct; 9(3):e093. PubMed ID: 37440791
    [No Abstract]   [Full Text] [Related]  

  • 7. Ignoring the elephant in the room-overregulated isotretinoin and unregulated dietary supplements in the United States.
    Zamil DH; Paidisetty PS; Wang LK
    Proc (Bayl Univ Med Cent); 2022; 35(6):892-893. PubMed ID: 36304632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in isotretinoin start, interruption, and early termination across race and sex in the iPLEDGE era.
    Charrow A; Xia FD; Lu J; Waul M; Joyce C; Mostaghimi A
    PLoS One; 2019; 14(3):e0210445. PubMed ID: 30913210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contraceptive counseling for iPLEDGE and its burden on dermatologists.
    Owens KE; Jiang SW; Nicholas MW
    Arch Dermatol Res; 2024 May; 316(6):287. PubMed ID: 38805059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isotretinoin: update on controversial issues.
    Prevost N; English JC
    J Pediatr Adolesc Gynecol; 2013 Oct; 26(5):290-3. PubMed ID: 24147278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of iPLEDGE: We pledge for more inclusive access to isotretinoin.
    Shah N; Kirkorian AY
    Pediatr Dermatol; 2021 Nov; 38 Suppl 2():183-184. PubMed ID: 34184311
    [No Abstract]   [Full Text] [Related]  

  • 12. Prescribing isotretinoin for transgender youth: A pledge for more inclusive care.
    Boos MD; Ginsberg BA; Peebles JK
    Pediatr Dermatol; 2019 Jan; 36(1):169-171. PubMed ID: 30318854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administrative Burden of iPLEDGE Deters Isotretinoin Prescriptions: Results From a Survey of Dermatologists.
    Lee G; Wolf JR; Somers KE
    Cutis; 2022 Jul; 110(1):44-47. PubMed ID: 36179224
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.